[go: up one dir, main page]

DE60125218D1 - Verfahren zur herstellung von humanem serumalbumin unter verwendung eines aufwarmschrittes - Google Patents

Verfahren zur herstellung von humanem serumalbumin unter verwendung eines aufwarmschrittes

Info

Publication number
DE60125218D1
DE60125218D1 DE60125218T DE60125218T DE60125218D1 DE 60125218 D1 DE60125218 D1 DE 60125218D1 DE 60125218 T DE60125218 T DE 60125218T DE 60125218 T DE60125218 T DE 60125218T DE 60125218 D1 DE60125218 D1 DE 60125218D1
Authority
DE
Germany
Prior art keywords
serum albumin
human serum
heating step
producing human
contaminants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60125218T
Other languages
English (en)
Other versions
DE60125218T2 (de
Inventor
T Nouchi
H Mizokami
Y Tajima
Y Miyatsu
M Sakaguchi
K Yagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of DE60125218D1 publication Critical patent/DE60125218D1/de
Publication of DE60125218T2 publication Critical patent/DE60125218T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE60125218T 2000-10-24 2001-10-24 Verfahren zur herstellung von humanen serumalbumin unter einbeziehen eines erwärmungsschrittes Expired - Lifetime DE60125218T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000324030 2000-10-24
JP2000324030A JP4798833B2 (ja) 2000-10-24 2000-10-24 加熱処理工程を含むヒト血清アルブミンの製造方法
PCT/JP2001/009336 WO2002034787A1 (fr) 2000-10-24 2001-10-24 Procede d"elaboration d"albumine de serum d"origine humaine comportant une etape de chauffage

Publications (2)

Publication Number Publication Date
DE60125218D1 true DE60125218D1 (de) 2007-01-25
DE60125218T2 DE60125218T2 (de) 2007-09-20

Family

ID=18801621

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60125218T Expired - Lifetime DE60125218T2 (de) 2000-10-24 2001-10-24 Verfahren zur herstellung von humanen serumalbumin unter einbeziehen eines erwärmungsschrittes

Country Status (12)

Country Link
US (1) US6908749B2 (de)
EP (1) EP1329462B1 (de)
JP (1) JP4798833B2 (de)
KR (1) KR100839937B1 (de)
CN (1) CN1313493C (de)
AT (1) ATE348111T1 (de)
AU (1) AU783638B2 (de)
CA (1) CA2395590C (de)
DE (1) DE60125218T2 (de)
DK (1) DK1329462T3 (de)
ES (1) ES2272548T3 (de)
WO (1) WO2002034787A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE331735T1 (de) * 2000-10-24 2006-07-15 Chemo Sero Therapeut Res Inst Verfahren zur monomerisierung von humanen serumalbumin-polymeren
ATE382057T1 (de) 2001-06-28 2008-01-15 Novo Nordisk As Stabile formulierung von modifiziertem glp-1
EP1567657A1 (de) * 2002-11-26 2005-08-31 Novo Nordisk A/S Verfahren zur reinigung von aus fermentation erhaltenen produkt
GB0305989D0 (en) * 2003-03-15 2003-04-23 Delta Biotechnology Ltd Agent
KR101308912B1 (ko) 2003-06-03 2013-09-23 노보 노르디스크 에이/에스 안정화된 약학적 펩티드 조성물
PL1633391T3 (pl) 2003-06-03 2012-03-30 Novo Nordisk As Stabilizowane farmaceutycznie kompozycje peptydowe
SI3300721T2 (sl) 2003-11-20 2025-05-30 Novo Nordisk A/S Peptidne formulacije, ki vsebujejo propilen glikol in ki so optimalne za proizvodnjo in uporabo v napravah za injiciranje
KR20070020204A (ko) * 2004-01-20 2007-02-20 쥬리디컬 파운데이션 더 케모-세로-쎄라퓨틱 리서치 인스티튜트 2가 양이온 존재 하에서 가열 처리에 의한 인간 혈청알부민의 제조 방법
PL1789434T3 (pl) 2004-08-31 2014-07-31 Novo Nordisk As Zastosowanie tris(hydroksymetylo)aminometanu do stabilizacji peptydów, polipeptydów i białek
ES2458991T5 (en) 2004-11-12 2025-10-14 Novo Nordisk As Stable formulations of insulinoptropic peptides
KR20080078010A (ko) 2005-12-22 2008-08-26 체에스엘 베링 게엠베하 옥타노에이트-감소된 사람 알부민
JP4936272B2 (ja) * 2006-02-13 2012-05-23 独立行政法人科学技術振興機構 バイオナノカプセルの効率的な精製法
WO2009003061A1 (en) 2007-06-25 2008-12-31 Fred Hutchinson Cancer Research Center Methods and compositions regarding polychalcogenide compositions
DK3429345T3 (da) 2016-10-04 2019-11-25 Albumedix Ltd Anvendelser af rekombinant gær-afledt serumalbumin
CN106749623B (zh) * 2016-12-09 2020-04-10 浙江大学 一种基于混合模式的扩张床吸附分离人血白蛋白方法
MX2020001525A (es) 2017-08-24 2020-03-20 Novo Nordisk As Composiciones de peptido similar al glucagon tipo 1 (glp-1) y sus usos.
EP4069200A1 (de) 2019-12-04 2022-10-12 Albumedix Ltd Verfahren und damit hergestellte zusammensetzungen
IL294521A (en) 2020-02-18 2022-09-01 Novo Nordisk As glp-1 compounds and their uses
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12151045B2 (en) 2020-12-28 2024-11-26 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
WO2026009167A1 (en) * 2024-07-02 2026-01-08 Csl Behring Ag A manufacturing process for albumin involving a heating step

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5071897A (de) * 1973-11-07 1975-06-14
US4025500A (en) * 1974-06-06 1977-05-24 Baxter Laboratories, Inc. Preparation of albumin by fractionation of blood plasma or serum
IL66614A (en) 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
US5004688A (en) * 1988-04-15 1991-04-02 Phillips Petroleum Company Purification of hepatitis proteins
JP2926722B2 (ja) 1988-10-20 1999-07-28 吉富製薬株式会社 アルブミン製剤及びその製造方法
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JPH04234326A (ja) * 1990-12-27 1992-08-24 Green Cross Corp:The アルブミン製剤及びその製法
JPH0671434A (ja) 1991-05-30 1994-03-15 Tadahiro Omi クリーンチャンバーの溶接方法
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JP3269504B2 (ja) * 1992-07-08 2002-03-25 三菱ウェルファーマ株式会社 ヒト血清アルブミンの製造方法
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
JP3840674B2 (ja) * 1994-08-31 2006-11-01 三菱ウェルファーマ株式会社 遺伝子操作に由来するヒト血清アルブミンの精製方法
AU3868197A (en) * 1996-08-23 1998-03-06 Kirin Beer Kabushiki Kaisha Yeast vectors and process for producing proteins with the use of the same
JP2885212B2 (ja) * 1997-01-06 1999-04-19 吉富製薬株式会社 遺伝子操作由来のヒト血清アルブミンより得られる高純度ヒト血清アルブミン含有組成物

Also Published As

Publication number Publication date
US6908749B2 (en) 2005-06-21
DK1329462T3 (da) 2007-01-22
EP1329462B1 (de) 2006-12-13
AU1093602A (en) 2002-05-06
AU783638B2 (en) 2005-11-17
EP1329462A1 (de) 2003-07-23
KR20020065609A (ko) 2002-08-13
ATE348111T1 (de) 2007-01-15
CN1313493C (zh) 2007-05-02
WO2002034787A1 (fr) 2002-05-02
US20020182680A1 (en) 2002-12-05
ES2272548T3 (es) 2007-05-01
EP1329462A4 (de) 2004-09-08
CA2395590C (en) 2012-12-11
CN1406246A (zh) 2003-03-26
DE60125218T2 (de) 2007-09-20
CA2395590A1 (en) 2002-05-02
KR100839937B1 (ko) 2008-06-20
JP4798833B2 (ja) 2011-10-19
JP2002128796A (ja) 2002-05-09

Similar Documents

Publication Publication Date Title
DE60125218D1 (de) Verfahren zur herstellung von humanem serumalbumin unter verwendung eines aufwarmschrittes
DE60333201D1 (de) Verfahren zur herstellung von proteinen
DE60228961D1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des mop-b
DE59806195D1 (de) Verfahren zur herstellung von aliphatischen alkoholen
ATE218036T1 (de) Verfahren zur herstellung eines proteinhydrolysates
ATE386736T1 (de) Verfahren zur herstellung von benzimidazol-2-yl - chinolinonderivaten
ATE334136T1 (de) Verfahren zur herstellung von azithromycin
ATE326145T1 (de) Verfahren zur herstellung von frischkäse mit sojaproteinzusatz
ATE316860T1 (de) Verfahren zur automatischen herstellung von brillenlinsen
DE69801154D1 (de) Verfahren zur herstellung von caprolactam in abwesenheit von katalysatoren durch kontakt von 6-aminocapronsäurederivaten mit überhitztem dampf
ATE245192T1 (de) Verfahren zur herstellung von gereinigten papillomavirus proteinen
DE60027932D1 (de) Verfahren zur herstellung von proteinhydrolysaten
ATE296287T1 (de) Verfahren zur herstellung von repaglinide
ATE447547T1 (de) Verfahren zur herstellung von phenylessigsäure derivaten
DE60009807D1 (de) Verfahren zur herstellung von (-)pyridobenzoxazin-carbonsäure-derivaten
ATE238316T1 (de) Verfahren zur herstellung von phosphonomethylglycin
DE50103231D1 (de) Verfahren zur herstellung von 7-(pyrazol-3-yl)benzoxazolen
ATE342254T1 (de) Verfahren zur herstellung von derivaten von [(1,5-diaryl)pyrazol-3-ylöpropansäure
ATE271053T1 (de) Verfahren zur herstellung von beta-hydroxyestern
ATA210899A (de) Verfahren zur herstellung von optisch aktiven cyanhydrinen unter verwendung von r-oxynitrilase
ATE386015T1 (de) Verfahren zur herstellung von alkyl-n-(3- dimethylamino)alkylcarbamaten
ATE238261T1 (de) Verfahren zur herstellung von orthoestern
DE60009074D1 (de) Verfahren zur herstellung von adipinsäure
ATE427937T1 (de) Verfahren zur herstellung von 2,3- pyridindicarbonsauren
DE60001379D1 (de) Verfahren zur herstellung von alkoholderivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition